Results 141 to 150 of about 11,231 (185)

Intra-abdominal abscess caused by Rhodotorula mucilaginosa in a peritoneal dialysis patient: a case report. [PDF]

CEN Case Rep
Abe S, Tanaka T, Matsubara N, Yamaguchi T, Goto M, Nakayama T.   +5 more
europepmc   +1 more source

Phenotypic and Molecular Assessment of <i>Candida</i> Species and Real-Time PCR Detection of Selected Virulence Genes in Immunocompromised Patients Admitted to Intensive Care Units. [PDF]

Pathogens
Altarawneh H, Salem EHM, Soliman AM, Elfakhrany AT, Abdelkareem HM, Mohsen Y, Gameel AM, Khalil HAE, Mostafa RG.   +8 more
europepmc   +1 more source

Clinical and Microbiological Characteristics of Early <i>Candidozyma auris</i> Cases in a Tertiary Hospital in Istanbul, Türkiye: A Retrospective Case Series. [PDF]

Antibiotics (Basel)
Nalça Erdin B, Aydın İ, Akkaya Y, Gürlek Ustabaşı MZ, Alıcıkuş Z, Turan C, Kılıç İH.   +6 more
europepmc   +1 more source

The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrations. [PDF]

J Antimicrob Chemother
Cree ML, Abdul-Aziz MH, Wallis SC, Won H, Sumi CD, Marjanovic D, Ordonez JL, Schlapbach LJ, Roberts JA.   +8 more
europepmc   +1 more source

Early antifungal resistance prediction based on MALDI-TOF mass spectrometry and machine learning. [PDF]

Sci Rep
Duroux D, Yang Y, Sattler J, Krauthammer M, Egli A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Micafungin

Annals of Pharmacotherapy, 2004
OBJECTIVE To review the pharmacology, mycology, chemistry, in vitro susceptibility, pharmacokinetics, clinical efficacy, safety, tolerability, dosage, and administration of micafungin, an echinocandin antifungal agent.
Blair, Jarvis, David P, Figgitt, Lesley J, Scott   +2 more
  +7 more sources

Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding [PDF]

Biopharmaceutics and Drug Disposition, 2011
Micafungin, a new echinocandin antifungal agent, has been widely used for the treatment of various fungal infections in human populations. Micafungin is predominantly cleared by biliary excretion and it binds extensively to plasma proteins (>99.5 ...
Patrick F Augustijns, Pieter Annaert, Souzan B Yanni   +2 more
exaly   +2 more sources

Micafungin for the treatment of invasive aspergillosis

Journal of Infection, 2014
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients, particularly those with neutropenia and those undergoing bone marrow or stem cell transplants.
S H Aliyu, D A Enoch, S H Aliyu
exaly   +2 more sources